PRESS RELEASE AB SCIENCE ANNOUNCES THE SETTLEMENT DELIVERY OF ITS LATEST CAPITAL INCREASE FOR €1.8 MILLION Paris, May 23, 2025, 8am CET AB Science S.A. (the “Company” or “AB Science”, Euronext – ...

Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, ...

Drugmakers are turning to biomarkers, like folate receptor alpha, and even cell therapies to tackle this deadly cancer in new ...

Here, we asked whether human intestinal mast cells (MC) might also be subject to immunoregulation ... Conclusions: Our data indicate that TGF-β1 acts as a novel potent inhibitor and modulator of human ...

A research team has developed a new class of compounds that effectively inhibit both wild-type CDK9 and its drug-resistant ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Aquagenic urticaria is the medical term for a water allergy. It makes showering painful and leads to skin reactions from ...

Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with ...

Compr Ophthalmol Update. 2005;6(2):85-101. Systemic corticosteroids are used in the treatment of severe inflammatory conditions of the eye, such as posterior uveitis or scleritis. Systemic ...

Each risk factor ... May 16, 2025 — Researchers have developed a method to confidently produce blood cell precursors from stem cells in mice, by activating a set of seven key genes in the ...

Eli Lilly said yesterday that it will acquire SiteOne Therapeutics, a biotech developing non-opioid pain drugs, for up to $1 ...